CTOs on the Move


 
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Kaden Health

Based in New York City, Kaden is a behavioral health company dedicated to solving the greatest healthcare challenges of our time with ground-breaking technology and unwavering humanity. Kaden`s first product tackles the opioid addiction crisis by positively influencing human behavior and making advanced technologies and proven treatments accessible to all so that no one has to fight opioid or any addiction alone.

Dyax Corp.

Dyax Corp. (Dyax) is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications.

AFID Therapeutics

AFID Therapeutics is a Lansing, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SciMar

SciMar is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

City of Gahanna

City of Gahanna, located in central ohio, offers family events, great parks and communities, plus the activities and businesses found at Creekside. Learn more about business development, emergency services, legislation, mayor’s court, city council, zon...